Health Technology Assessment Review: Exploring ...

By HEOR Staff Writer

February 12, 2024

Introduction: The Office of Health Technology Assessment Review has launched the second consultation of the Health Technology Assessment (...
WHO – 4th Fair Pricing Forum
Digital Rehabilitation for COPD Patients: NICE recommends
The Patient-Centric Approach in Health Economics
Direct Oral Anticoagulants Efficacy Versus Vitamin K Antagonists
Pharmaceutical Pricing and Reimbursement in Latin America
The Power of Prevention: The Untapped Potential of Adult Immunisation Programmes
NICE’s Preparations for Evaluating New Alzheimer’s Treatments
Pioneering Treatments for Paroxysmal Nocturnal Hemoglobinuria
A New Dawn in Breast Cancer Treatment: Ultra-Hypofractionated Radiotherapy
Spinal Muscular Atrophy: A Comprehensive Review of Newborn Screening, Treatme...
The Value-Based Pricing and Market Access of Valbenazine: A Cost Effective Ev...
Navigating the Maze: The EU Pharma Legislation Review and its Implications